Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway
about
iNKT Cells and Their Potential Lipid Ligands during Viral InfectionPotential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.How Informative is the Immune Response Against Surrogate Tumor Antigens to Assess Antitumor Immunity?The strength of the T cell response against a surrogate tumor antigen induced by oncolytic VSV therapy does not correlate with tumor controlLipid antigens in immunity.Bcl-xL regulates CD1d-mediated antigen presentation to NKT cells by altering CD1d trafficking through the endocytic pathway.Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunityVaricella-Zoster virus ORF12 protein triggers phosphorylation of ERK1/2 and inhibits apoptosis.CD1d expression on and regulation of murine hematopoietic stem and progenitor cells.Involvement of the cellular phosphatase DUSP1 in vaccinia virus infection.Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-β/Smad signalling pathway.Cell Signaling Pathways That Regulate Antigen PresentationHuman herpesvirus 7 u21 downregulates classical and nonclassical class I major histocompatibility complex molecules from the cell surfaceHerpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function.Specific NFkappaB subunit activation and kinetics of cytokine induction in adenoviral keratitis.A Thr/Ser dual residue motif in the cytoplasmic tail of human CD1d is important for the down-regulation of antigen presentation following a herpes simplex virus 1 infection.
P2860
Q26800120-CA56D25B-8EEF-46D6-9512-600865ADBB86Q33579385-AB277889-E581-446B-9B18-A91186C5C64AQ33710433-4B1F25C3-A69A-4160-B789-F70F0601CC7CQ33724224-DE83391C-E10B-41C9-918E-E1EC663C7FCDQ34025822-ADC2A4F8-5F04-4733-8B13-8F95C2CF6216Q34216393-11B2D258-45AA-44CD-B591-AFEB517830D6Q34626935-AEE53F72-3446-4036-B956-1EBE900B3EB7Q35826325-1AC5B33D-70C6-4010-8583-25F7F9B6CA86Q36057586-A84F3E37-25D5-41CF-BA94-274DA7FC1E25Q37308720-FEC6A271-8AA4-4CC1-BF4E-5AE099DA57E0Q38764629-8AB46465-B8AF-4724-B70A-C9D7CF9071FEQ38978579-3E525200-99B1-499B-AA79-3B4EE5B4D649Q39002838-993BD9D7-745E-4761-9624-5C065A4D4EA1Q39747252-D49A24CF-5DC3-4BDD-AF15-5B2D59CD9F3FQ42850482-2EF32937-CAF8-458A-83CC-2AD8BA7FB2C9Q42948998-5C1720F8-877D-40FA-B893-FBD83FB34B23Q45351037-5E5B29E2-2CE1-4BB4-AD6E-D3F931983B23
P2860
Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Vesicular stomatitis virus mat ...... vation of the p38 MAPK pathway
@en
type
label
Vesicular stomatitis virus mat ...... vation of the p38 MAPK pathway
@en
prefLabel
Vesicular stomatitis virus mat ...... vation of the p38 MAPK pathway
@en
P2093
P2860
P356
P1433
P1476
Vesicular stomatitis virus mat ...... vation of the p38 MAPK pathway
@en
P2093
Daniel Shaji
Gourapura J Renukaradhya
Masood A Khan
P2860
P304
12535-12542
P356
10.1128/JVI.00881-08
P407
P577
2008-09-24T00:00:00Z